glp-1 microdosing chart THE PROGRAM Alternative dosing regimens of GLP-1

The well-established healthcare infrastructure and widespread access to advanced medications like Semaglutide and Tirzepatide facilitated rapid adoption

Effects of switching from liraglutide or dulaglutide to subcutaneous semaglutide on glucose metabolism and treatment satisfaction in patients with type 2 diabetes: protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 Study)

We dug in and did a survey for GLP-1

C., & Xu, R

34 In the double-blind study, seven patients received subcutaneous exenatide twice daily and eight patients received placebo

Pandey S, Mangmool S, Parichatikanond W